Sandy Coombs
About Sandy Coombs
Sandy Coombs is the Senior Vice President of Corporate Affairs & Investor Relations at Alkermes, with over 20 years of experience in investor relations and corporate communications.
Current Role at Alkermes
Sandy Coombs is serving as the Senior Vice President of Corporate Affairs & Investor Relations at Alkermes. She plays a key role in leading the company's investor relations and corporate communications strategies. Coombs is responsible for managing relationships with investors and ensuring clear communication of Alkermes’ business objectives to stakeholders.
Career at Alkermes
Sandy Coombs has had a progressive career at Alkermes, having been with the company since 2009. She started as an Associate Director in Corporate Communications and gradually advanced through various roles in Investor Relations, including Director, Senior Director, Vice President, and currently as Senior Vice President. Throughout her tenure, she significantly contributed to the company’s evolution into a global biopharmaceutical entity.
Professional Background
Prior to joining Alkermes, Sandy Coombs held the role of Investor Relations Manager at Oscient Pharmaceuticals for five years. She also has experience as a Credit Risk Analyst with Deutsche Bank and an intern at Fairchild Semiconductor. These roles provided her with a strong foundation in financial analysis and risk management.
Educational Background
Sandy Coombs holds a Master of Science in Finance from Boston College’s Carroll School of Management, achieved in 2010. She also earned a Bachelor of Science in Finance from the same institution, completed in 2003. Additionally, she studied at the EM Strasbourg Business School in 2001.
Industry Experience
With over 20 years of experience in investor relations and corporate communications, Sandy Coombs has an extensive background in the pharmaceutical industry, including more than 15 years of direct experience. She has been instrumental in managing strategic communications and crisis management, as well as launching multiple investor relations programs at Alkermes.